Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2006-12-15

FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA granted approval of a supplemental application for levothyroxine sodium by Mylan Pharmaceuticals Inc., updating the drug’s labeling or formulation. Levo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVOTHYROXINE SODIUM (levothyroxine sodium)

Snippet

SUPPL AP for LEVOTHYROXINE SODIUM (LEVOTHYROXINE SODIUM)